297 related articles for article (PubMed ID: 26940479)
1. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479
[TBL] [Abstract][Full Text] [Related]
2. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.
Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
J Neurol; 2016 Sep; 263(9):1847-61. PubMed ID: 27357003
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
[TBL] [Abstract][Full Text] [Related]
4. High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease.
Matsui Y; Satoh K; Miyazaki T; Shirabe S; Atarashi R; Mutsukura K; Satoh A; Kataoka Y; Nishida N
BMC Neurol; 2011 Oct; 11():120. PubMed ID: 21970675
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
[TBL] [Abstract][Full Text] [Related]
6. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
[TBL] [Abstract][Full Text] [Related]
7. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
8. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
[TBL] [Abstract][Full Text] [Related]
9. Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel.
Meiner Z; Kahana E; Baitcher F; Korczyn AD; Chapman J; Cohen OS; Milo R; Aharon-Perez J; Abramsky O; Gabizon R; Rosenmann H
J Neurol; 2011 Feb; 258(2):255-62. PubMed ID: 20827556
[TBL] [Abstract][Full Text] [Related]
10. The Levels of Tau Isoforms Containing Exon-2 and Exon-10 Segments Increased in the Cerebrospinal Fluids of the Patients with Sporadic Creutzfeldt-Jakob Disease.
Chen C; Zhou W; Lv Y; Shi Q; Wang J; Xiao K; Chen LN; Zhang BY; Dong XP
Mol Neurobiol; 2016 Aug; 53(6):3999-4009. PubMed ID: 26188647
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity evaluation of multiple neurodegenerative proteins for Creutzfeldt-Jakob disease diagnosis using a deep-learning approach.
Lee SM; Hyeon JW; Kim SJ; Kim H; Noh R; Kim S; Lee YS; Kim SY
Prion; 2019 Jan; 13(1):141-150. PubMed ID: 31306078
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.
Bahl JM; Heegaard NH; Falkenhorst G; Laursen H; Høgenhaven H; Mølbak K; Jespersgaard C; Hougs L; Waldemar G; Johannsen P; Christiansen M
Neurobiol Aging; 2009 Nov; 30(11):1834-41. PubMed ID: 18339451
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.
Zanusso G; Fiorini M; Ferrari S; Gajofatto A; Cagnin A; Galassi A; Richelli S; Monaco S
Int J Mol Sci; 2011; 12(9):6281-92. PubMed ID: 22016658
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs.
Llorens F; Karch A; Golanska E; Schmitz M; Lange P; Sikorska B; Liberski PP; Zerr I
Dement Geriatr Cogn Disord; 2017; 43(1-2):71-80. PubMed ID: 28056460
[TBL] [Abstract][Full Text] [Related]
16. Detection of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease Patients Using a New Automated Capillary Western Assay.
Fourier A; Dorey A; Perret-Liaudet A; Quadrio I
Mol Neurobiol; 2018 Apr; 55(4):3537-3545. PubMed ID: 28509083
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.
Coulthart MB; Jansen GH; Olsen E; Godal DL; Connolly T; Choi BC; Wang Z; Cashman NR
BMC Neurol; 2011 Oct; 11():133. PubMed ID: 22032272
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients.
Schmitz M; Llorens F; Pracht A; Thom T; Correia Â; Zafar S; Ferrer I; Zerr I
Aging (Albany NY); 2016 Nov; 8(11):2927-2935. PubMed ID: 27852982
[TBL] [Abstract][Full Text] [Related]
19. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
Blennow K; Johansson A; Zetterberg H
Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
